IR

Investor Relations

经营信息

Hugel has designated the regulations in the Articles of Incorporation for the basic principles of operating the company. In accordance with the Articles of Incorporation, the general meeting is convened by the board of directors and major decisions are made related to stockholders’ rights and resolutions. For more details on the Articles of Incorporation, download the Articles of Incorporation document.

Download Articles of
Incorporation
Board of Directors
Title Name R&R Term
Non-executive Director Suk-yong Cha Chair of the Board of Directors,
Non-executive Director		 23.03 ~ 26.03
Executive Director Jihoon Sohn Executive Director 18.03 ~ 24.03
Non-executive Director Suhhong Hur Non-executive Director 22.04 ~ 25.04
Non-executive Director Michael Keyoung Non-executive Director 22.04 ~ 25.04
Non-executive Director Taehyoung Lee Member of the Audit Committee 22.04 ~ 25.04
Independent Director Patrick Holt Member of the Audit Committee 22.04 ~ 25.04
Independent Director Seungmin Chee Chair of the Audit Committee 22.04 ~ 25.04
BOD Activities in 2022
Time Date Agenda Result Participation
7 2022.07.01
  • 1: Appointment of the chair of the Board of Directors
 Approved 7/7
6 2022.05.19
  • 1: Convocation of the extraordinary general meeting of shareholders
  • 2: Setting a record date
  • 3: Approval on adoption of electronic voting system
 Approved 7/7
5 2022.04.14
  • 1: Convocation of the extraordinary general meeting of shareholders
  • 2: Debt split and purchase change of convertible bonds
Approved 7/7
4 2022.04.07
  • 1: Acquisition of trust contract for treasury shares
 Approved 7/7
3 2022.03.08
  • 1: Enactment of the remuneration policy for executive
  • 2: Amendments to executive severance policy
  • 3: Convocation of the 21st annual general meeting of shareholders
  • 4: Adjusting a record date for the extraordinary general meeting of shareholders
  • 5: Cancellation of stock options
 Approved 7/7
2 2022.02.10
  • 1: Approval of financial statements for the 21st fiscal year(2021.01.01-2021.12.31)
  • 2: Approval of business report for the 21st fiscal year(2021.01.01-2021.12.31)
  • 3: Liquidation of the subsidiary in Weihai
  • 4: Liquidation of the subsidiary in Vietnam
Approved 7/7
1 2022.01.17
  • 1: Setting a record date for the extraordinary general meeting of shareholders
 Approved 7/7
BOD Activities in 2021
Time Date Agenda Result Participation
8 2021.12.16
  • 1: Setting a record date for dividend
 Approved 7/7
7 2021.12.13
  • 1: Acquisition of trust contract for treasury shares
  • 2: Cancellation of treasury shares
 Approved 6/7
6 2021.10.01
  • 1: Setting a record date for the extraordinary general meeting of shareholders
 Approved 6/7
5 2021.09.09
  • 1: Extension of trust contract for treasury shares
 Approved 6/7
4 2021.04.08
  • 1: Determination of exercise stock options
  • 2: Transfer of real estate purchase contract and termination/settlement of real estate sale contract
 Approved 5/7
3 2021.03.26
  • 1: Re-appointment of co-chairperson for the board of directors
  • 2: Appointment of CEO
 Approved 7/7
2 2021.03.10
  • 1: Acquisition of trust contract for treasury shares
 Approved 7/7
1 2021.02.09
  • 1: Approval of financial statements for the 20th fiscal year(2020.01.01-2020.12.31)
  • 2: Approval of business report for the 20th fiscal year(2020.01.01-2020.12.31)
  • 3: Convocation of the 20th annual general meeting of shareholders
  • 4: Enactment of compliance control standards
  • 5: Appointment of compliance officer
 Approved 7/7
The Audit Committee
Name Work Experience INTEREST WITH MAJOR SHAREHOLDER Term
Seungmin Chee
  • Ph.D. in Accounting, University of California at Berkeley
  • Assistant Professor of Accounting, Korea University Business School
  • Non-Executive Director, Korea Institute of Marine Science & Technology Promotion
  • Commissioner, Korean Accounting System Review Committee, Securities & Futures Commission
  • Associate Professor, University of Oregon
 None 22.04 ~ 25.04
Patrick Holt
  • B.S. in Chemistry & Biochemistry, Monash University
  • President, Cordis(Cardinal Health Inc.)
  • Non-Executive Director, Ascenda Loyalty
  • Vice President, Allergan
  • President Director, Merck & Co., Inc.
None 22.04 ~ 25.04
Taehyoung Lee
  • MBA, University of Washington
  • CFO, GS Holdings Corp.
  • Senior Managing Director of Management Planning Department, GS Energy Corporation
  • CEO, Incheon Total Energy Company
  • CFO, PM Team Leader, Vice President, GS Holdings Corp.
 None 22.04 ~ 25.04